- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02032849
Air-impingement Manipulation to Clear Subglottic Secretion Compared With Drainage Tube in Prolonged Intubated Patients
August 13, 2014 updated by: Jie Li, Beijing Chao Yang Hospital
Air-impingement Manipulation to Clear Subglottic Secretion Compared With Drainage Tube in Prolonged Intubated Patients, a Randomized Controlled Trial.
This is a randomized controlled trial compared two methods to drainage subglottic secretion in prolonged intubated patients.After enrolled, patients are randomized assigned to intermittent subglottic secretion drainage group and air-impingement manipulation group.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Ventilator-associated pneumonia (VAP) is the most frequent infection occurring in patients who are admitted to the ICU.
The accumulation of respiratory secretions in the subglottic space is a well-proven cause of VAP.
Therefore, prevention should include the aspiration of secretions from the subglottic space.
Investigators invented a manual method with high-flow air produced by resuscitator to impinge secretion from the subglottic space to oral cavity.
This method has been granted as a patent by Chinese national intellectual property patent office, it has been used in investigators' daily work for more than 10 years and more than 20 Chinese ICUs have used it everyday.
Investigators want to compare it with conventional method which uses a special intubation tube with an independent dorsal lumen to suction subglottic secretion.
Study Type
Interventional
Enrollment (Anticipated)
240
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jie Li, Master
- Phone Number: 86-13552976483
- Email: lijie8497@hotmail.com
Study Contact Backup
- Name: Sun Bing
- Phone Number: 86-13911151075
- Email: ricusunbing@126.com
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100020
- Recruiting
- Beijing Chaoyang Hospital
-
Contact:
- Jie Li, Master
- Phone Number: 86-13552976483
- Email: cyhrt@sina.cn
-
Contact:
- Bing Sun, Doctor
- Phone Number: 86-13911151075
- Email: ricusunbing@gmail.com
-
Principal Investigator:
- Jie Li, Master
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Should meet all the criteria:
- Intubation less than 24 hours before admitting respiratory intensive care unit;
- Anticipated intubation for more than 72 hours;
- Anticipated survival time is more than 2 weeks
Exclusion Criteria:
Meet any of these criteria:
- PEEP≥10cmH2O or FiO2≥0.8;
- unstable hemodynamics;
- severe bulla and pneumothorax;
- enrolled in other study;
- cuff leak test is positive.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Manual air-impingement operation
A method which we invented to clear subglottic secretion
|
The conventional method with a special tube to drainage subglottic secretion
|
Active Comparator: subglottic secretion drainage
The conventional method with a special tube to drainage subglottic secretion
|
A method which we invented to clear subglottic secretion
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Percentage of participants with ventilator-associated pneumonia
Time Frame: Up to 28 days
|
Up to 28 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
ICU mortality
Time Frame: Participants will be followed for the duration of ICU stay, an expected average of 4 weeks
|
Participants will be followed for the duration of ICU stay, an expected average of 4 weeks
|
Other Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Invasive ventilation duration
Time Frame: Participants will be followed for the duration of invasive ventilation, an expected average of 7-10 days
|
Participants will be followed for the duration of invasive ventilation, an expected average of 7-10 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jie Li, Master, Beijing Chao Yang Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2014
Primary Completion (Anticipated)
June 1, 2016
Study Completion (Anticipated)
December 1, 2016
Study Registration Dates
First Submitted
December 30, 2013
First Submitted That Met QC Criteria
January 9, 2014
First Posted (Estimate)
January 10, 2014
Study Record Updates
Last Update Posted (Estimate)
August 15, 2014
Last Update Submitted That Met QC Criteria
August 13, 2014
Last Verified
August 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BJCYHRT-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ventilator Associated Pneumonia
-
Hospital Alemão Oswaldo CruzMinistry of Health, BrazilRecruitingHealthcare-Associated Pneumonia | Ventilator-Associated Pneumonia | Healthcare Associated InfectionBrazil
-
King Edward Memorial HospitalCompletedNosocomial Pneumonia | Healthcare-Associated Pneumonia | Aspiration Pneumonia | Ventilator-Associated PneumoniaIndia
-
Cubist Pharmaceuticals LLCCompletedLung Diseases | Healthcare-Associated Pneumonia | Ventilator-Associated Pneumonia
-
Arpida AGTerminatedHospital-Acquired Pneumonia | Ventilator-Associated Pneumonia | Health-Care-Associated Pneumonia
-
University Hospital OlomoucCompletedVentilator-Associated Pneumonia
-
Aydin Adnan Menderes UniversityNot yet recruitingVentilator-Associated PneumoniaTurkey
-
Istanbul Medeniyet UniversityRecruiting
-
University Hospital, ToulouseRecruitingVentilator-associated PneumoniaFrance
-
Erasmus Medical CenterChiesi Farmaceutici S.p.A.CompletedVentilator Associated Pneumonia (VAP)Spain, Netherlands
-
Andrzej Frycz Modrzewski Krakow UniversityCompletedVAP - Ventilator Associated PneumoniaPoland
Clinical Trials on Manual air-impingement operation
-
Beijing Chao Yang HospitalUnknownVentilator Associated Pneumonia
-
Peking University Third HospitalNot yet recruitingOsteoarthritis, Knee
-
Ullevaal University HospitalWithdrawnSpinal Cord Injury | TetraplegiaNorway
-
Medtrum FranceAxonal-BiostatemNot yet recruitingType 1 DiabetesFrance
-
Bozyaka Training and Research HospitalNot yet recruitingSpinal Anesthesia | Hypothermia Following Anesthesia | Prewarming | Urological Cancer | Core TemperatureTurkey
-
University of Alabama at BirminghamNational Heart, Lung, and Blood Institute (NHLBI)Recruiting